Evidence map›Paper›PMID 35182761›Full record

ArticleClinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases2022

High SARS-CoV-2 seroprevalence among health care workers in Bamako referral hospitals: a prospective multisite cross-sectional study (ANRS COV11).

Almoustapha I Maiga, Mahamadou Saliou, Amadou Kodio, Abdoulaye M Traore, Garan Dabo, Philippe Flandre, Djeneba B Fofana, Karim Ammour, Nanzie O M E Tra, Oumar Dolo and 2 more

Registry-linked trialAbstract readLetter
In one paragraph

Article in Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04710316 (Étude de l'épidémie de SARS-CoV-2 Dans Les Services Hospitaliers de Bamako, Mali), which is not on this map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04710316 nacompletednot on this map

Étude de l'épidémie de SARS-CoV-2 Dans Les Services Hospitaliers de Bamako, Mali

TypeinterventionalSponsorInstitut National de la Santé Et de la Recherche Médicale, FranceRan2021 to 2022Enrolled450ConditionsCovid19ArmsSARS-CoV-2 screening by molecular biology, Serological screening
3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Almoustapha I MaigaDépartement de Biologie Médicale, Centre Hospitalier Universitaire Gabriel Touré, Bamako, Mali; Unité d'Epidémiologie Moléculaire de la Résistance du VIH aux ARV, UCRC/SEREFO, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Mahamadou SaliouService de Médecine, Centre Hospitalier Universitaire Gabriel Touré, Bamako, Mali.
Amadou KodioUnité d'Epidémiologie Moléculaire de la Résistance du VIH aux ARV, UCRC/SEREFO, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Abdoulaye M TraoreService de Maladies Infectieuses, Centre Hospitalier Universitaire du Point-G, Bamako, Mali.
Garan DaboService de Médecine, Hôpital du Mali, Bamako, Mali.
Philippe FlandreSorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique, Paris, France.
Djeneba B FofanaUnité d'Epidémiologie Moléculaire de la Résistance du VIH aux ARV, UCRC/SEREFO, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali; Sorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Saint-Antoine, Service de Virologie, Paris, France.
Karim AmmourINSERM PRC, Paris, France.
Nanzie O M E TraUnité d'Epidémiologie Moléculaire de la Résistance du VIH aux ARV, UCRC/SEREFO, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Oumar DoloUnité d'Epidémiologie Moléculaire de la Résistance du VIH aux ARV, UCRC/SEREFO, University of Sciences, Techniques and Technologies of Bamako, Bamako, Mali.
Anne-Geneviève MarcelinSorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Pitié-Salpêtrière, Service de Virologie, Paris, France.
Eve TodescoSorbonne Université, INSERM, Institut Pierre Louis d'Épidémiologie et de Santé Publique (iPLESP), Assistance Publique-Hôpitaux de Paris (AP-HP), Hôpital Pitié-Salpêtrière, Service de Virologie, Paris, France. Electronic address: eve.todesco@aphp.fr.

Funding

Development of a Multiplex Quantitative PCR Assay for HIV and Hepatitis B Virus, for Low- and middle Income CountriesK43TW011957 · FIC · UNIV OF SCIENCES, TECH & TECH OF BAMAKO · PI FOFANA, DJENEBA BOCAR · 2021 to 2025
$499k
FIC NIH HHS K43 TW011957
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19SARS-CoV-2Antibodies, ViralCross-Sectional StudiesHealth PersonnelHospitalsHumansProspective StudiesReferral and ConsultationSeroepidemiologic StudiesAntibodies, Viral

Identifiers

PMID35182761
PMCPMC8848726

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.